Published in Vaccine Weekly, July 21st, 1997
The modified version is called HGP-30W, where W stands for worldwide. It is hoped that HGP-30W will provide better worldwide protection against a large number of HIV subtypes.
Even though HIV infection is a major problem in the U.S. and Europe, the developing world has an even greater need for a protective AIDS vaccine. Due to the rapid mutation of AIDS, virtually all AIDS vaccine candidates in human testing in the U.S., if successful, would be primarily useful only against U.S. and European HIV subtypes, but much less so against Asian...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly